Prognosis and Survival Analysis of 922,317 Lung Cancer Patients from the US Based on the Most Recent Data from the SEER Database (April 15, 2021)

References

• Howlader N, Forjaz G, Mooradian MJ, et al. The effect of advances in Lung-Cancer treatment on population mortality. N Engl J Med. 2020;383(7):640–649. doi:10.1056/NEJMoa1916623
   PubMed Web of Science ®Google Scholar
• Tolwin Y, Gillis R, Peled N. Gender and lung cancer-SEER-based analysis. Ann Epidemiol. 2020;46:14–19. doi:10.1016/j.annepidem.2020.04.003
   PubMed Web of Science ®Google Scholar
• Houston KA, Henley SJ, Li J, White MC, Richards TB. Patterns in lung cancer incidence rates and trends by histologic type in the United States, 2004–2009. Lung Cancer. 2014;86(1):22–28. doi:10.1016/j.lungcan.2014.08.001
   PubMed Web of Science ®Google Scholar
• Henley SJ, Richards TB, Underwood JM, Eheman CR, Plescia M, McAfee TA. Lung cancer incidence trends among men and women–United States, 2005–2009. MMWR Morb Mortal Wkly Rep. 2014;63(1):1–5.
   PubMed Web of Science ®Google Scholar
• Song CK, Guo ZX, Shen XY, et al. Prognostic factors analysis and nomogram Construction of dual primary lung cancer: a population study. Biomed Res Int. 2020;2020:7206591. doi:10.1155/2020/7206591
   PubMed Web of Science ®Google Scholar
• Jia B, Zheng Q, Wang J, et al. A nomogram model to predict death rate among non-small cell lung cancer (NSCLC) patients with surgery in surveillance, epidemiology, and end results (SEER) database. BMC Cancer. 2020;20(1):666. doi:10.1186/s12885-020-07147-y
   PubMed Web of Science ®Google Scholar
• Siegel R, DeSantis C, Virgo K, et al. Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin. 2012;62(4):220–241. doi:10.3322/caac.21149
   PubMed Web of Science ®Google Scholar
• Garcia MC, Rossen LM, Bastian B, et al. Potentially excess deaths from the five leading causes of death in metropolitan and nonmetropolitan counties - United States, 2010–2017. MMWR Surveill Summ. 2019;68(10):1–11. doi:10.15585/mmwr.ss6810a1
   PubMed Web of Science ®Google Scholar
• Coleman NC, Burnett RT, Ezzati M, Marshall JD, Robinson AL, Pope CA 3rd. Fine particulate matter exposure and cancer incidence: analysis of SEER cancer registry data from 1992–2016. Environ Health Perspect. 2020;128(10):107004. doi:10.1289/ehp7246
   PubMed Web of Science ®Google Scholar
• Lu T, Yang X, Huang Y, et al. Trends in the incidence, treatment, and survival of patients with lung cancer in the last four decades. Cancer Manag Res. 2019;11:943–953. doi:10.2147/cmar.S187317
   PubMed Web of Science ®Google Scholar
• Xu L, Zhang G, Song S, Zheng Z. Surgery for small cell lung cancer: a Surveillance, Epidemiology, and End Results (SEER) survey from 2010 to 2015. Medicine. 2019;98(40):e17214. doi:10.1097/md.0000000000017214
   PubMed Web of Science ®Google Scholar
• Zheng XQ, Huang JF, Lin JL, et al. Incidence, prognostic factors, and a nomogram of lung cancer with bone metastasis at initial diagnosis: a population-based study. Transl Lung Cancer Res. 2019;8(4):367–379. doi:10.21037/tlcr.2019.08.16
   PubMed Web of Science ®Google Scholar
• Liang W, He J, Shen Y, et al. Impact of examined lymph node count on precise staging and long-term survival of resected non-small-cell lung cancer: a population study of the US SEER database and a Chinese multi-institutional registry. J Clin Oncol. 2017;35(11):1162–1170. doi:10.1200/jco.2016.67.5140
   PubMed Web of Science ®Google Scholar
• Cagney DN, Martin AM, Catalano PJ, et al. Incidence and prognosis of patients with brain metastases at diagnosis of systemic malignancy: a population-based study. Neuro Oncol. 2017;19(11):1511–1521. doi:10.1093/neuonc/nox077
   PubMed Web of Science ®Google Scholar
• Donin N, Filson C, Drakaki A, et al. Risk of second primary malignancies among cancer survivors in the United States, 1992 through 2008. Cancer. 2016;122(19):3075–3086. doi:10.1002/cncr.30164
   PubMed Web of Science ®Google Scholar
• Meza R, Meernik C, Jeon J, Cote ML. Lung cancer incidence trends by gender, race and histology in the United States, 1973–2010. PLoS One. 2015;10(3):e0121323. doi:10.1371/journal.pone.0121323
   PubMed Web of Science ®Google Scholar
• Ten Haaf K, van Rosmalen J, de Koning HJ. Lung cancer detectability by test, histology, stage, and gender: estimates from the NLST and the PLCO trials. Cancer Epidemiol Biomarkers Prev. 2015;24(1):154–161. doi:10.1158/1055-9965.Epi-14-0745
   PubMed Web of Science ®Google Scholar
• Pilleron S, Maringe C, Charvat H, Atkinson J, Morris E, Sarfati D. Age disparities in lung cancer survival in New Zealand: the role of patient and clinical factors. Lung Cancer. 2021;157:92–99. doi:10.1016/j.lungcan.2021.05.015
   PubMed Web of Science ®Google Scholar
• Sachs E, Sartipy U, Jackson V. Sex and survival after surgery for lung cancer: a Swedish nationwide cohort. Chest. 2021;159(5):2029–2039. doi:10.1016/j.chest.2020.11.010
   PubMed Web of Science ®Google Scholar
• Torre LA, Siegel RL, Jemal A. Lung cancer statistics. Adv Exp Med Biol. 2016;893:1–19. doi:10.1007/978-3-319-24223-1_1
   PubMed Web of Science ®Google Scholar
• Chang JW, Asamura H, Kawachi R, Watanabe S. Gender difference in survival of resected non-small cell lung cancer: histology-related phenomenon? J Thorac Cardiovasc Surg. 2009;137(4):807–812. doi:10.1016/j.jtcvs.2008.09.026
   PubMed Web of Science ®Google Scholar
• Cainap C, Pop LA, Balacescu O, Cainap SS. Early diagnosis and screening in lung cancer. Am J Cancer Res. 2020;10(7):1993–2009.
   PubMed Web of Science ®Google Scholar
• Hernandez-Arenas LA, Lin L, Yang Y, et al. Initial experience in uniportal subxiphoid video-assisted thoracoscopic surgery for major lung resections. Eur J Cardiothorac Surg. 2016;50(6):1060–1066. doi:10.1093/ejcts/ezw189
   PubMed Web of Science ®Google Scholar
• Yang L, Wang S, Gerber DE, et al. Main bronchus location is a predictor for metastasis and prognosis in lung adenocarcinoma: a large cohort analysis. Lung Cancer. 2018;120:22–26. doi:10.1016/j.lungcan.2018.03.011
   PubMed Web of Science ®Google Scholar
• Ganti AK, Shostrom V, Alorabi M, et al. Early stage non-small-cell lung Cancer in octogenarian and older patients: a SEER database analysis. Clin Lung Cancer. 2016;17(4):285–291. doi:10.1016/j.cllc.2015.11.014
   PubMed Web of Science ®Google Scholar
• Yang CC, Fong Y, Lin LC, et al. The age-adjusted Charlson comorbidity index is a better predictor of survival in operated lung cancer patients than the Charlson and Elixhauser comorbidity indices. Eur J Cardiothorac Surg. 2018;53(1):235–240. doi:10.1093/ejcts/ezx215
   PubMed Web of Science ®Google Scholar
• Sachs E, Jackson V, Sartipy U. Household disposable income and long-term survival after pulmonary resections for lung cancer. Thorax. 2020;75(9):764–770. doi:10.1136/thoraxjnl-2019-214321
   PubMed Web of Science ®Google Scholar
• Nwagbara UI, Ginindza TG, Hlongwana KW. Health systems influence on the pathways of care for lung cancer in low- and middle-income countries: a scoping review. Global Health. 2020;16(1):23. doi:10.1186/s12992-020-00553-8
   PubMed Web of Science ®Google Scholar
• Maruthappu M, Watkins J, Noor AM, et al. Economic downturns, universal health coverage, and cancer mortality in high-income and middle-income countries, 1990–2010: a longitudinal analysis. Lancet. 2016;388(10045):684–695. doi:10.1016/s0140-6736(16)00577-8
   PubMed Web of Science ®Google Scholar
• Singh GK, Siahpush M. Widening rural-urban disparities in life expectancy, U.S. 1969–2009. Am J Prev Med. 2014;46(2):e19–29. doi:10.1016/j.amepre.2013.10.017
   PubMed Web of Science ®Google Scholar
• Zhang Y, Ma X, Shen X, et al. Surgery for pre- and minimally invasive lung adenocarcinoma. J Thorac Cardiovasc Surg. 2020. doi:10.1016/j.jtcvs.2020.11.151
   Web of Science ®Google Scholar
• Drake JA, Sullivan JL, Weksler B. Adjuvant chemotherapy improves survival in patients with completely resected T3N0 non-small cell lung cancer invading the chest wall. J Thorac Cardiovasc Surg. 2018;155(4):1794–1802. doi:10.1016/j.jtcvs.2017.11.091
   PubMed Web of Science ®Google Scholar
• Guo D, Wang M, Shen Z, Zhu J. A new immune signature for survival prediction and immune checkpoint molecules in lung adenocarcinoma. J Transl Med. 2020;18(1):123. doi:10.1186/s12967-020-02286-z
   PubMed Web of Science ®Google Scholar
• Kumarakulasinghe NB, van Zanwijk N, Soo RA. Molecular targeted therapy in the treatment of advanced stage non-small cell lung cancer (NSCLC). Respirology. 2015;20(3):370–378. doi:10.1111/resp.12490
   PubMed Web of Science ®Google Scholar
• Yang S, Zhang Z, Wang Q. Emerging therapies for small cell lung cancer. J Hematol Oncol. 2019;12(1):47. doi:10.1186/s13045-019-0736-3
   PubMed Web of Science ®Google Scholar
• Iams WT, Porter J, Horn L. Immunotherapeutic approaches for small-cell lung cancer. Nat Rev Clin Oncol. 2020;17(5):300–312. doi:10.1038/s41571-019-0316-z
   PubMed Web of Science ®Google Scholar
• Farago AF, Yeap BY, Stanzione M, et al. Combination Olaparib and temozolomide in relapsed small-cell lung cancer. Cancer Discov. 2019;9(10):1372–1387. doi:10.1158/2159-8290.Cd-19-0582
   PubMed Web of Science ®Google Scholar
• Li J, Ye C, Mansmann UR. Comparing patient-derived xenograft and computational response prediction for targeted therapy in patients of early-stage large cell lung cancer. Clin Cancer Res. 2016;22(9):2167–2176. doi:10.1158/1078-0432.Ccr-15-2401
   PubMed Web of Science ®Google Scholar
• Williams CD, Salama JK, Moghanaki D, Karas TZ, Kelley MJ. Impact of race on treatment and survival among U.S. veterans with early-stage lung cancer. J Thorac Oncol. 2016;11(10):1672–1681. doi:10.1016/j.jtho.2016.05.030
   PubMed Web of Science ®Google Scholar
• Richards TB, Henley SJ, Puckett MC, et al. Lung cancer survival in the United States by race and stage (2001–2009): findings from the Concord-2 study. Cancer. 2017;123 Suppl 24(Suppl 24):5079–5099. doi:10.1002/cncr.31029
   PubMed Web of Science ®Google Scholar
• Klugman M, Xue X, Ginsberg M, Cheng H, Rohan T, Hosgood HD 3rd. Hispanics/Latinos in the Bronx have improved survival in non-small cell lung cancer compared with non-Hispanic whites. J Racial Ethn Health Disparities. 2020;7(2):316–326. doi:10.1007/s40615-019-00660-2
   PubMed Web of Science ®Google Scholar
• Soneji S, Tanner NT, Silvestri GA, Lathan CS, Black W. Racial and ethnic disparities in early-stage lung cancer survival. Chest. 2017;152(3):587–597. doi:10.1016/j.chest.2017.03.059
   PubMed Web of Science ®Google Scholar